<it>NPC1L1 </it>haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe
Guy Justin, Hegele Robert A, Ban Matthew R and 1 more
Lipids in Health and Disease · 2005
doi:10.1186/1476-511x-4-16 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Background</p> <p><it>NPC1L1 </it>encodes a putative intestinal sterol transporter which is the likely target for ezetimibe, a new type of lipid-lowering medication. We previously reported rare non-synonymous mutations in <it>NPC1L1 </it>in an individual who had no plasma lipoprotein response to ezetimibe. We next hypothesized that common variants in <it>NPC1L1 </it>would underlie less extreme inter-individual variations in the plasma LDL cholesterol response to ezetimibe.</p> <p>Results</p> <p>In 101 dyslipidemic subjects, we found that <it>NPC1L1 </it>haplotype was significantly associated with inter-individual variation in the response of plasma LDL cholesterol to treatment with ezetimibe for 12 weeks. Specifically, about one subject in eight lacked the common <it>NPC1L1 </it>haplotype 1735C-25342A-27677T and these subjects had a significantly greater reduction in plasma LDL cholesterol with ezetimibe than subjects with at least one copy of this haplotype (-35.9+4.0 versus -23.6+1.6 percent reduction, P = 0.0054). This was paralleled by a similar non-significant trend of between-haplotype difference in reduction of total cholesterol.</p> <p>Conclusion</p> <p>These preliminary pharmacogenetic results suggest that <it>NPC1L1 </it>variation is associated with inter-individual variation in response to ezetimibe treatment.</p>
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.